Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

The UK's NHS has approved a first daily pill, relugolix combination therapy, to treat endometriosis symptoms. The new ...

A new treatment for a common painful condition and two other drugs will be made cheaper to improve access to treatment for ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the ...

This announcement is all about making treatment cheaper and easier, so women can focus on getting the care they need.” ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

A new combination pill, relugolix–estradiol–norethisterone, has been approved for treating endometriosis on the NHS. This marks the first long-term, daily oral treatment for the condition, offering a ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Multiple women’s health medications are set to become more affordable when they're added to the government-subsidised list of ...

The contraceptive pill Slinda, endometriosis treatment Ryego and an IVF drug will be made cheaper via the Pharmaceutical Benefits Scheme, the Albanese government will announce.

The Albanese government will make treatments for IVF and endometriosis cheaper as the government rolls out further ...